We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The US Food and Drug Administration (FDA) has announced that two companies are voluntarily recalling batches of ranitidine tablets and one company is voluntarily recalling lots of nizatidine tablets in the US.
Over the past several weeks, the U.S. Food and Drug Association (FDA) has communicated about the detection of an impurity known as N-nitrosodimethylamine (NDMA) in ...